Cargando…

Progresses towards safe and efficient gene therapy vectors

The emergence of genetic engineering at the beginning of the 1970′s opened the era of biomedical technologies, which aims to improve human health using genetic manipulation techniques in a clinical context. Gene therapy represents an innovating and appealing strategy for treatment of human diseases,...

Descripción completa

Detalles Bibliográficos
Autores principales: Chira, Sergiu, Jackson, Carlo S., Oprea, Iulian, Ozturk, Ferhat, Pepper, Michael S., Diaconu, Iulia, Braicu, Cornelia, Raduly, Lajos-Zsolt, Calin, George A., Berindan-Neagoe, Ioana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741561/
https://www.ncbi.nlm.nih.gov/pubmed/26362400
_version_ 1782414018799992832
author Chira, Sergiu
Jackson, Carlo S.
Oprea, Iulian
Ozturk, Ferhat
Pepper, Michael S.
Diaconu, Iulia
Braicu, Cornelia
Raduly, Lajos-Zsolt
Calin, George A.
Berindan-Neagoe, Ioana
author_facet Chira, Sergiu
Jackson, Carlo S.
Oprea, Iulian
Ozturk, Ferhat
Pepper, Michael S.
Diaconu, Iulia
Braicu, Cornelia
Raduly, Lajos-Zsolt
Calin, George A.
Berindan-Neagoe, Ioana
author_sort Chira, Sergiu
collection PubMed
description The emergence of genetic engineering at the beginning of the 1970′s opened the era of biomedical technologies, which aims to improve human health using genetic manipulation techniques in a clinical context. Gene therapy represents an innovating and appealing strategy for treatment of human diseases, which utilizes vehicles or vectors for delivering therapeutic genes into the patients' body. However, a few past unsuccessful events that negatively marked the beginning of gene therapy resulted in the need for further studies regarding the design and biology of gene therapy vectors, so that this innovating treatment approach can successfully move from bench to bedside. In this paper, we review the major gene delivery vectors and recent improvements made in their design meant to overcome the issues that commonly arise with the use of gene therapy vectors. At the end of the manuscript, we summarized the main advantages and disadvantages of common gene therapy vectors and we discuss possible future directions for potential therapeutic vectors.
format Online
Article
Text
id pubmed-4741561
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-47415612016-03-03 Progresses towards safe and efficient gene therapy vectors Chira, Sergiu Jackson, Carlo S. Oprea, Iulian Ozturk, Ferhat Pepper, Michael S. Diaconu, Iulia Braicu, Cornelia Raduly, Lajos-Zsolt Calin, George A. Berindan-Neagoe, Ioana Oncotarget Review The emergence of genetic engineering at the beginning of the 1970′s opened the era of biomedical technologies, which aims to improve human health using genetic manipulation techniques in a clinical context. Gene therapy represents an innovating and appealing strategy for treatment of human diseases, which utilizes vehicles or vectors for delivering therapeutic genes into the patients' body. However, a few past unsuccessful events that negatively marked the beginning of gene therapy resulted in the need for further studies regarding the design and biology of gene therapy vectors, so that this innovating treatment approach can successfully move from bench to bedside. In this paper, we review the major gene delivery vectors and recent improvements made in their design meant to overcome the issues that commonly arise with the use of gene therapy vectors. At the end of the manuscript, we summarized the main advantages and disadvantages of common gene therapy vectors and we discuss possible future directions for potential therapeutic vectors. Impact Journals LLC 2015-09-04 /pmc/articles/PMC4741561/ /pubmed/26362400 Text en Copyright: © 2015 Chira et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Review
Chira, Sergiu
Jackson, Carlo S.
Oprea, Iulian
Ozturk, Ferhat
Pepper, Michael S.
Diaconu, Iulia
Braicu, Cornelia
Raduly, Lajos-Zsolt
Calin, George A.
Berindan-Neagoe, Ioana
Progresses towards safe and efficient gene therapy vectors
title Progresses towards safe and efficient gene therapy vectors
title_full Progresses towards safe and efficient gene therapy vectors
title_fullStr Progresses towards safe and efficient gene therapy vectors
title_full_unstemmed Progresses towards safe and efficient gene therapy vectors
title_short Progresses towards safe and efficient gene therapy vectors
title_sort progresses towards safe and efficient gene therapy vectors
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741561/
https://www.ncbi.nlm.nih.gov/pubmed/26362400
work_keys_str_mv AT chirasergiu progressestowardssafeandefficientgenetherapyvectors
AT jacksoncarlos progressestowardssafeandefficientgenetherapyvectors
AT opreaiulian progressestowardssafeandefficientgenetherapyvectors
AT ozturkferhat progressestowardssafeandefficientgenetherapyvectors
AT peppermichaels progressestowardssafeandefficientgenetherapyvectors
AT diaconuiulia progressestowardssafeandefficientgenetherapyvectors
AT braicucornelia progressestowardssafeandefficientgenetherapyvectors
AT radulylajoszsolt progressestowardssafeandefficientgenetherapyvectors
AT calingeorgea progressestowardssafeandefficientgenetherapyvectors
AT berindanneagoeioana progressestowardssafeandefficientgenetherapyvectors